Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Share price still dropping

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jan 18, 2021 12:16pm

161 Views

Post# 32320264

RE:RE:Share price still dropping

They would be restricted from doing any insider buying for now. That would have to wait but I am not sure for how long.

scarlet1967 wrote:
To make a short term damage control among other things company should do it would be a great vote of confidence if insiders would purchase a meaningful amount of the shares.If we look at the NASH comps most of them have a double digit percentage of shares held by insiders vs THTX's 1.5%!

jeffm34 wrote: Looks like it will test $3.00 cnd